View in EDS

[The trade-off and selection of efficacy endpoints: controversies and challenges between progression-free survival and overall survival in clinical trials of gynecological tumors].

Saved in:

Bibliographic Details
Title:	[The trade-off and selection of efficacy endpoints: controversies and challenges between progression-free survival and overall survival in clinical trials of gynecological tumors].
Authors:	Wang DF; Department of Gynecologic Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Sichuan Provincial Key Medical Laboratory of Gynecologic Oncology, Health Commission of Sichuan Province, Chengdu, Sichuan 610041, China., Pei J; Department of Clinical Research, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China., Zhang GN; Department of Gynecologic Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Sichuan Provincial Key Medical Laboratory of Gynecologic Oncology, Health Commission of Sichuan Province, Chengdu, Sichuan 610041, China.
Source:	Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2026 Mar 03; Vol. 106 (8), pp. 687-692.
Publication Type:	English Abstract; Journal Article
Journal Info:	Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print ISSN: 0376-2491 (Print) Linking ISSN: 03762491 NLM ISO Abbreviation: Zhonghua Yi Xue Za Zhi Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	0376-2491
DOI:	10.3760/cma.j.cn112137-20251220-03362